Eryn L. Werry

1.5k total citations
44 papers, 1.1k citations indexed

About

Eryn L. Werry is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Eryn L. Werry has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 13 papers in Physiology. Recurrent topics in Eryn L. Werry's work include Adenosine and Purinergic Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Eryn L. Werry is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Eryn L. Werry collaborates with scholars based in Australia, United Kingdom and United States. Eryn L. Werry's co-authors include Michael Kassiou, Guo Jun Liu, Glenda M. Halliday, Max R. Bennett, Lars M. Ittner, John R. Hodges, Matthew C. Kiernan, Jillian J. Kril, Fiona Bright and Clement T. Loy and has published in prestigious journals such as International Journal of Molecular Sciences, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Eryn L. Werry

44 papers receiving 1.1k citations

Peers

Countries citing papers authored by Eryn L. Werry

Since Specialization

Citations

This map shows the geographic impact of Eryn L. Werry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eryn L. Werry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eryn L. Werry more than expected).

Fields of papers citing papers by Eryn L. Werry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eryn L. Werry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eryn L. Werry. The network helps show where Eryn L. Werry may publish in the future.

Co-authorship network of co-authors of Eryn L. Werry

This figure shows the co-authorship network connecting the top 25 collaborators of Eryn L. Werry. A scholar is included among the top collaborators of Eryn L. Werry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eryn L. Werry. Eryn L. Werry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and evaluation of [11C]DPA-813 and [18F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Wissam Beaino, Esther Kooijman, Eryn L. Werry, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Robert C. Schuit, Michael Kassiou, Albert D. Windhorst, Jonathan J. Danon	1
2	Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis 2024 ·Seminars in Nuclear Medicine ·(unknown), (unknown), Michael Kassiou, Eryn L. Werry, Jonathan J. Danon	9
3	Synthesis and Antitumour Evaluation of Tricyclic Indole‐2‐Carboxamides against Paediatric Brain Cancer Cells 2024 ·ChemMedChem ·(unknown), (unknown), Eryn L. Werry, (unknown), (unknown), Clémentine Mercé, Ulrich D. Kadolsky, Alan D. Payne, Michael Kassiou, Simone Treiger Sredni, Alka Saxena, Hendra Gunosewoyo	1
4	iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype 2024 ·Journal of Neuroinflammation ·Michael A. Sullivan, (unknown), (unknown), (unknown), Margaret Sunde, G. Gregory Neely, Cesar L. Moreno, (unknown), Eryn L. Werry, Michael Kassiou	7
5	Three‐dimensional bioprinting of stem cell‐derived central nervous system cells enables astrocyte growth, vasculogenesis, and enhances neural differentiation/function 2023 ·Biotechnology and Bioengineering ·Michael A. Sullivan, (unknown), Alexander Volkerling, Martin Engel, Eryn L. Werry, Michael Kassiou	14
6	Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells 2021 ·RSC Medicinal Chemistry ·Shahinda S. R. Alsayed, (unknown), (unknown), (unknown), Eryn L. Werry, Chiang‐Ching Huang, Li-Fang Yu, Michael Kassiou, Simone Treiger Sredni, Hendra Gunosewoyo	4
7	Pharmacological characterization of a structural hybrid P2X7R antagonist using ATP and LL-37 2021 ·European Journal of Pharmacology ·Alexander Jackson, Eryn L. Werry, (unknown), (unknown), Shane M. Wilkinson, (unknown), (unknown), (unknown), Michael Kassiou	7
8	Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism 2020 ·European Journal of Medicinal Chemistry ·(unknown), Eryn L. Werry, (unknown), (unknown), (unknown), Jonathan J. Danon, Andrew P. Montgomery, Jonathan J. Du, (unknown), David E. Hibbs, Lars M. Ittner, Tristan A. Reekie, Michael Kassiou	8
9	Targeting the Oxytocin System: New Pharmacotherapeutic Approaches 2018 ·Trends in Pharmacological Sciences ·(unknown), Eryn L. Werry, Tristan A. Reekie, Timothy A. Katte, (unknown), Michael Kassiou	49
10	Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists 2017 ·European Journal of Medicinal Chemistry ·Timothy A. Katte, Tristan A. Reekie, Eryn L. Werry, (unknown), Rochelle Boyd, (unknown), (unknown), Mark Connor, Michael Kassiou	5
11	Derivatives of the pyrazolo[1,5- a ]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma 2016 ·European Journal of Pharmaceutical Sciences ·Eryn L. Werry, (unknown), Melissa L. Barron, Samuel D. Banister, (unknown), Michael Kassiou	14
12	Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors 2015 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Eryn L. Werry, Tristan A. Reekie, Mark Connor, Michael Kassiou	11
13	N-substituted 8-aminopentacyclo[5.4.0.02,6.03,10.05,9]undecanes as σ receptor ligands with potential neuroprotective effects 2013 ·Bioorganic & Medicinal Chemistry ·Samuel D. Banister, (unknown), Melissa L. Barron, Eryn L. Werry, Michael Kassiou	17
14	Glutamate potentiates lipopolysaccharide–stimulated interleukin-10 release from neonatal rat spinal cord astrocytes 2012 ·Neuroscience ·Eryn L. Werry, Guo Jun Liu, Michael D. Lovelace, Rajini Nagarajah, Max R. Bennett	7
15	Effect of age on proliferation‐regulating factors in human adult neurogenic regions 2010 ·Journal of Neurochemistry ·Eryn L. Werry, (unknown), Glenda M. Halliday, Perminder S. Sachdev, Kay L. Double	21
16	Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions? 2010 ·Progress in Neurobiology ·Kay L. Double, Stefanie Reyes, Eryn L. Werry, Glenda M. Halliday	96
17	Glutamate‐stimulated ATP release from spinal cord astrocytes is potentiated by substance P 2006 ·Journal of Neurochemistry ·Eryn L. Werry, Guo Jun Liu, Max R. Bennett	53
18	Purine Release from Spinal Cord Microglia after Elevation of Calcium by Glutamate 2006 ·Molecular Pharmacology ·Guo Jun Liu, (unknown), Eryn L. Werry, Max R. Bennett	56
19	Secretion of ATP from Schwann cells in response to uridine triphosphate 2005 ·European Journal of Neuroscience ·Guo Jun Liu, Eryn L. Werry, Max R. Bennett	58
20	Mechanisms of secretion of ATP from cortical astrocytes triggered by uridine triphosphate 2003 ·Neuroreport ·Andrea Abdipranoto, Guo Jun Liu, Eryn L. Werry, Max R. Bennett	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact